List of bibliographic references
Number of relevant bibliographic references: 8.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Humans |
| 3 | Aged |
| 3 | Female |
| 3 | Male |
| 2 | Adolescent |
| 2 | Adult |
| 2 | Aged, 80 and over |
| 2 | Antineoplastic Agents (therapeutic use) |
| 2 | Middle Aged |
| 2 | Treatment Outcome |
| 2 | Young Adult |
| 1 | Abnormal chromosome A2 |
| 1 | Abnormal chromosome E17 |
| 1 | Anaplastic lymphoma kinase |
| 1 | Angiogenesis Inhibitors (administration & dosage) |
| 1 | Antibodies, Monoclonal, Humanized (administration & dosage) |
| 1 | Antibodies, Monoclonal, Murine-Derived (administration & dosage) |
| 1 | Antimetabolites, Antineoplastic (therapeutic use) |
| 1 | Antineoplastic Combined Chemotherapy Protocols (administration & dosage) |
| 1 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 1 | Azacitidine (therapeutic use) |
| 1 | B-Lymphocyte |
| 1 | Benzamides (therapeutic use) |
| 1 | Bevacizumab |
| 1 | Blast Crisis (drug therapy) |
| 1 | Blast Crisis (pathology) |
| 1 | Carcinogenesis |
| 1 | Case study |
| 1 | Child |
| 1 | Child, Preschool |
| 1 | Chromosome translocation |
| 1 | Cladribine (therapeutic use) |
| 1 | Clathrin |
| 1 | Cyclophosphamide (administration & dosage) |
| 1 | Disease Management |
| 1 | Doxorubicin (administration & dosage) |
| 1 | Eosinophilia (drug therapy) |
| 1 | Eosinophilia (epidemiology) |
| 1 | Eosinophilia (genetics) |
| 1 | Follow-Up Studies |
| 1 | Gene rearrangement |
| 1 | Human |
| 1 | Hybrid gene |
| 1 | Imatinib Mesylate |
| 1 | Infant |
| 1 | International Agencies |
| 1 | Large cell lymphoma |
| 1 | Leukemia, Hairy Cell (diagnosis) |
| 1 | Leukemia, Hairy Cell (drug therapy) |
| 1 | Leukemia, Myeloid (drug therapy) |
| 1 | Leukemia, Myeloid (genetics) |
| 1 | Leukemia, Myeloid, Acute (drug therapy) |
| 1 | Leukemia, Myeloid, Acute (mortality) |
| 1 | Leukemia, Myeloid, Acute (pathology) |
| 1 | Lymphoma, Large B-Cell, Diffuse (diagnosis) |
| 1 | Lymphoma, Large B-Cell, Diffuse (drug therapy) |
| 1 | Neoplasm Recurrence, Local (diagnosis) |
| 1 | Neoplasm Recurrence, Local (drug therapy) |
| 1 | Neoplasm Staging |
| 1 | Neoplasm, Residual (diagnosis) |
| 1 | Neoplasm, Residual (drug therapy) |
| 1 | Oncogene Proteins, Fusion (genetics) |
| 1 | Pentostatin (therapeutic use) |
| 1 | Piperazines (therapeutic use) |
| 1 | Prednisone (administration & dosage) |
| 1 | Prognosis |
| 1 | Prospective Studies |
| 1 | Protein kinase |
| 1 | Pyrimidines (therapeutic use) |
| 1 | Receptor, Platelet-Derived Growth Factor beta (genetics) |
| 1 | Remission Induction |
| 1 | Survival Rate |
| 1 | Translocation, Genetic |
| 1 | Vincristine (administration & dosage) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "John F. Seymour"
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i \
-Sk "John F. Seymour" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Canada
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= John F. Seymour
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
